ReviewThe FEBS journal2026
Targeting the microbiota-miRNA-protease axis: A new therapeutic avenue in melanoma.
Elias N Katsoulieris et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewThe FEBS journal2026
Elias N Katsoulieris et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.